Rictor-A Mediator of Progression and Metastasis in Lung Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Rictor and mTORC2 play key roles in lung cancer metastasis. Targeting Rictor-mTORC2 offers a promising therapeutic strategy to inhibit cancer progression and reduce metastasis in lung carcinoma patients.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Lung carcinoma is a leading cause of cancer death, often characterized by high metastatic rates.
- The Rictor protein, part of the mTORC2 complex, is implicated in cellular functions promoting metastasis.
- RICTOR gene amplification and Rictor overexpression are linked to mTORC2 activation and cancer progression.
Purpose Of The Study
- To review recent advances on the role of Rictor and mTORC2 in lung cancer.
- To highlight Rictor and mTORC2 as potential therapeutic targets for lung cancer treatment.
Main Methods
- This is a narrative review based on literature searches.
- Searched PubMed and Google Scholar using keywords: Rictor, RICTOR amplification, mTORC2, Rictor complexes, lung cancer, metastasis, progression, mTOR inhibitors.
Main Results
- Rictor/mTORC2 signaling facilitates epithelial-mesenchymal transition and metastasis.
- RICTOR amplification/Rictor overexpression indicates mTORC2 activation and serves as a potential biomarker.
- Preclinical studies show Rictor inhibitors can reduce tumor cell migration and metastasis.
Conclusions
- Rictor and mTORC2 are crucial in lung cancer progression and metastasis.
- Targeting Rictor and mTORC2 presents a promising therapeutic avenue for lung cancer treatment.
- Further development of Rictor-specific inhibitors could offer novel strategies against lung cancer metastasis.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...